January 04, 2025 03:07 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tesla Cybertruck with fuel and fireworks explodes near Donald Trump's Las Vegas hotel, 1 killed | US: Mass shooting at a New York nightclub, 11 people shot | Truck driver who rammed into New Orleans crowd flying ISIS flag identified as US Army veteran Shamsud-Din Jabbar | SRK, Akshay Kumar praise PM Modi's global initiative to take Indian cinema to a greater scale | Manipur CM N Biren Singh responds after Congress leader asks him 'why can't PM' visit' violence-hit northeastern state | Suchir Balaji death: Indian-American techie's parents claim autopsy report reveals murder | Indian-origin doctor among 2 killed in UAE light aircraft crash | 'We will take revenge, with interest:' Suvendu Adhikari warns Mamata Banerjee over her Sandeshkhali claims | 'Forgive and forget mistake': Manipur CM N Biren Singh apologises for ethnic clashes | Deeply malicious and utterly condemnable: Pinarayi Vijayan on BJP leader Nitesh Rane's 'Kerala is mini Pakistan' remark

AstraZeneca Vaccine almost powerless against South African coronavirus strain: Study

Feb 07, 2021, at 04:05 pm

London/Sputnik: The Oxford/AstraZeneca coronavirus vaccine only offers limited protection against the South African strain of the coronavirus, a study due to be released on Monday shows.

Vietnam approves AstraZeneca vaccine against COVID-19

Jan 30, 2021, at 10:07 pm

Bangkok/Sputnik: The Vietnamese authorities have approved the use of the AtraZeneca/Oxford University vaccine against COVID-19, the government news portal reported on Saturday.

AstraZeneca CEO says firm found 'Winning Formula' for vaccine against COVID-19

Dec 28, 2020, at 04:12 pm

Moscow/Sputnik: AstraZeneca has found a "winning formula" to boost the efficacy of its vaccine against COVID-19, which has been developed in conjunction with the University of Oxford, CEO Pascal Soriot told the UK's Sunday Times newspaper.

AstraZeneca's COVID-19 vaccine trial to resume in US

Oct 24, 2020, at 03:28 pm

Washington/Xinhua: Multinational pharmaceutical company AstraZeneca said on Friday it will resume the trial of its experimental COVID-19 vaccine in the United States, which has been paused since September.

Serum Institute gets DCGI nod to resume Covid-19 vaccine

Sep 16, 2020, at 04:25 pm

New Delhi/IBNS: The Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, media reports said. 

India reports biggest daily spike in Covid-19 cases, adds over 95,000 infections in 24 hours

Sep 10, 2020, at 04:18 pm

New Delhi/IBNS: India, a country of 1.3 billion people, on Thursday reported the biggest daily spike by adding over 95,000 fresh infections in the last 24 hours.

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse reaction seen in participant

Sep 09, 2020, at 01:30 pm

London:  Pharmaceutical company AstraZeneca has halted the Phase 3 study testing of a Covid-19 vaccine after a suspected serious adverse reaction was seen in a participant in the United Kingdom, media reports said.

Nirsevimab reduced respiratory syncytial virus infections and hospitalisations in preterm infants in Phase IIb trial :  AstraZeneca

Jul 31, 2020, at 02:12 pm

Nirsevimab showed a significant reduction in medically-attended lower respiratory tract infections (LRTI) and hospitalisations caused by respiratory syncytial virus (RSV) in healthy preterm infants in a positive Phase IIb trial published in the New England Journal of Medicine.